Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6001 AL 6015

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran E, Mercken M, De Strooper B.

Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505.

Alzheimer's disease: emerging trends in small molecule therapies

Mohamed T, Rao PP.

Curr Med Chem. 2011;18(28):4299-320. doi: 10.2174/092986711797200435.

Role of serotonin in Alzheimer's disease: a new therapeutic target?

Geldenhuys WJ, Van der Schyf CJ.

CNS Drugs. 2011 Sep 1;25(9):765-81. doi: 10.2165/11590190-000000000-00000.

Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A.

Cell Tissue Res. 2012 Jan;347(1):291-301. doi: 10.1007/s00441-011-1230-6. Epub 2011 Aug 31.

Effects of gender on burden among caregivers of Alzheimer's patients

Akpınar B, Küçükgüçlü O, Yener G.

J Nurs Scholarsh. 2011 Sep;43(3):248-54. doi: 10.1111/j.1547-5069.2011.01402.x. Epub 2011 Jul 18.

[Dementia: progress in diagnosis and treatment; editorial, towards the preclinical treatment of Alzheimer disease]

Iwatsubo T.

Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2089-91. doi: 10.2169/naika.100.2089.

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

Chen S, Liu AR, An FM, Yao WB, Gao XD.

Age (Dordr). 2012 Oct;34(5):1211-24. doi: 10.1007/s11357-011-9303-8. Epub 2011 Sep 8.

Assessment of the information provided by the medical specialist on Alzheimer's disease and that retained by the patient caregivers

Molinuevo JL, Hernández B; Grupo de Trabajo del Estudio TRACE.

Neurologia. 2012 Oct;27(8):453-71. doi: 10.1016/j.nrl.2011.05.009. Epub 2011 Sep 9.

Selective liver X receptor modulators (SLiMs): what use in human health?

Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S.

Mol Cell Endocrinol. 2012 Apr 4;351(2):129-41. doi: 10.1016/j.mce.2011.08.036. Epub 2011 Sep 1.

[Pharmacological and clinical profiles of galantamine (Reminyl(®))]

Nagino K, Shikinami K, Saito T, Harada Y.

Nihon Yakurigaku Zasshi. 2011 Sep;138(3):122-6. doi: 10.1254/fpj.138.122.

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review

Thompson PA, Wright DE, Counsell CE, Zajicek J.

Int Psychogeriatr. 2012 May;24(5):689-97. doi: 10.1017/S1041610211001116. Epub 2011 Sep 13.

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

[Current trend of immunotherapy for Alzheimer's disease]

Matsumoto SE, Tabira T.

Nihon Rinsho. 2011 Sep;69(9):1628-32.

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine

Anekonda TS, Quinn JF.

Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias